Hybribio Biotech
Overview
Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnosti
Market Cap$3.5B
Revenue$661.4M
Listed OnShenzhen Stock Exchange
Ticker300639
CEOMs. Jianyu Wang
HeadquartersChaozhou